Clinical Oncology
Volume 22, Issue 6 , Pages 405-412 , August 2010

Management of Thyroid Nodules and Surgery for Differentiated Thyroid Cancer

  • N.G. Iyer
  • ,
  • A.R. Shaha

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: A.R. Shaha, Head and Neck Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. Tel: +1-212-639-7649; fax: +1-212-717-3302.

Received 2 February 2010 ,Accepted 16 March 2010.

References 

  1. dos Santos Silva I, Swerdlow AJ. Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer. 1993;67:330–340
  2. Pettersson B, Adami HO, Wilander E, Coleman MP. Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type. Int J Cancer. 1991;48:28–33
  3. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. Jama. 2006;295:2164–2167
  4. Randolph GW, Thompson GB, Branovan DI, Tuttle RM. Treatment of thyroid cancer: 2007—a basic review. Int J Radiat Oncol Biol Phys. 2007;69:S92–S97
  5. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer. 1998;83:2638–2648[see comments]
  6. Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007;246:375–381discussion 381–374
  7. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–1214
  8. Atli M, Akgul M, Saryal M, Daglar G, Yasti AC, Kama NA. Thyroid incidentalomas: prediction of malignancy and management. Int Surg. 2006;91:237–244
  9. Gough J, Scott-Coombes D, Fausto Palazzo F. Thyroid incidentaloma: an evidence-based assessment of management strategy. World J Surg. 2008;32:1264–1268
  10. Howlett DC, Speirs A. The thyroid incidentaloma—ignore or investigate?. J Ultrasound Med. 2007;26:1367–1371
  11. Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q. 2006;22:231–238discussion 239–240
  12. Kim EK, Park CS, Chung WY, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol. 2002;178:687–691
  13. Deandrea M, Mormile A, Veglio M, et al. Fine-needle aspiration biopsy of the thyroid: comparison between thyroid palpation and ultrasonography. Endocr Pract. 2002;8:282–286
  14. Leenhardt L, Hejblum G, Franc B, et al. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab. 1999;84:24–28
  15. Wienke JR, Chong WK, Fielding JR, Zou KH, Mittelstaedt CA. Sonographic features of benign thyroid nodules: interobserver reliability and overlap with malignancy. J Ultrasound Med. 2003;22:1027–1031
  16. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002;87:1941–1946
  17. Shaha AR. Controversies in the management of thyroid nodule. Laryngoscope. 2000;110:183–193
  18. Shaha AR. Advances in the management of thyroid cancer. Int J Surg. 2005;3:213–220
  19. Nikiforova MN, Nikiforov YE. Molecular diagnostics and predictors in thyroid cancer. Thyroid. 2009;19:1351–1361
  20. Katz SC, Shaha A. PET-associated incidental neoplasms of the thyroid. J Am Coll Surg. 2008;207:259–264
  21. Robbins RJ, Wan Q, Grewal RK, et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab. 2006;91:498–505
  22. Are C, Hsu JF, Ghossein RA, Schoder H, Shah JP, Shaha AR. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Ann Surg Oncol. 2007;14:3210–3215
  23. Shah JP, Loree TR, Dharker D, Strong EW. Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg. 1993;166:331–335
  24. Shah JP. Re: extent of surgery affects papillary thyroid cancer. Ann Surg. 2008;247:1082–1083author reply 1083–1084
  25. Shaha A. Treatment of thyroid cancer based on risk groups. J Surg Oncol. 2006;94:683–691
  26. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg. 1992;164:658–661
  27. Shaha A. Selective surgical management of well-differentiated thyroid cancer. Ann NY Acad Sci. 2008;1138:58–64
  28. Grillo HC, Suen HC, Mathisen DJ, Wain JC. Resectional management of thyroid carcinoma invading the airway. Ann Thorac Surg. 1992;54:3–9discussion 9–10
  29. Clayman GL, Shellenberger TD, Ginsberg LE, et al. Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck. 2009;31:1152–1163
  30. Mazzaferri EL, Doherty GM, Steward DL. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid. 2009;19:683–689
  31. Sugitani I, Fujimoto Y, Yamada K, Yamamoto N. Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World J Surg. 2008;32:2494–2502
  32. Chisholm EJ, Kulinskaya E, Tolley NS. Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope. 2009;119:1135–1139
  33. Grubbs EG, Evans DB. Role of lymph node dissection in primary surgery for thyroid cancer. J Natl Compr Canc Netw. 2007;5:623–630
  34. Patel KN, Shaha AR. Locally advanced thyroid cancer. Curr Opin Otolaryngol Head Neck Surg. 2005;13:112–116
  35. Shaha AR. Management of the neck in thyroid cancer. Otolaryngol Clin North Am. 1998;31:823–831

PII: S0936-6555(10)00097-X

doi: 10.1016/j.clon.2010.03.009

Clinical Oncology
Volume 22, Issue 6 , Pages 405-412 , August 2010